Kiniksa Pharmaceuticals International, plc (KNSA)

CIK 1730430 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kiniksa Pharmaceuticals International, plc.

Recent SEC filings

FiledFormAccession number
Nov 3, 202640001464583-26-000010
Nov 3, 202640001835458-26-000014
Nov 3, 202640001741533-26-000012
Nov 3, 202640001532218-26-000018
Nov 3, 202640001857177-26-000010
Nov 2, 20261440001921094-26-001138
Oct 30, 20261440001921094-26-001126
Oct 30, 20261440001921094-26-001125
Oct 30, 20261440001921094-26-001127
Oct 30, 20261440001921094-26-001129
Oct 27, 202610-Q0001104659-26-119186
Oct 27, 20268-K0001730430-26-000037
Oct 22, 20268-K0001730430-26-000034
Sep 3, 202640001464583-26-000008
Sep 3, 20261440001921094-26-000988
Sep 3, 202640001835458-26-000012
Sep 3, 202640001532218-26-000014
Sep 3, 202640001741533-26-000010
Sep 3, 202640001532218-26-000016
Sep 3, 202640001857177-26-000008
Aug 21, 202640001384243-26-000014
Aug 4, 202640001454983-26-000008
Jul 31, 202640001337798-26-000004
Jul 29, 20261440001921094-26-000768
Jul 29, 2026SCHEDULE 13G0002012383-26-002783